Dextromethorphan (Monograph)
Brand names: Alka-Seltzer Plus Cold & Cough, Alka-Seltzer Plus Day Cold, Alka-Seltzer Plus Night Cold, Cheracol D Cough, Children’s Vicks NyQuil Cold/Cough,
... show all 52 brands
Drug class: Antitussives
ATC class: RO5DA09
VA class: RE302
CAS number: 6700-34-1
Introduction
Antitussive agent; derivative of levorphanol.
Uses for Dextromethorphan
Cough
Temporary relief of coughs (antitussive, cough suppressant) caused by minor throat and bronchial irritation that may occur with common colds, allergies, or inhaled irritants.
Used in fixed combination with other agents (e.g., acetaminophen, brompheniramine, chlorpheniramine, doxylamine, guaifenesin, phenylephrine, pseudoephedrine) for the temporary relief of coughs and/or other symptoms (e.g., rhinorrhea, sneezing, lacrimation, itching eyes, oronasopharyngeal itching, nasal congestion) associated with seasonal (e.g., hay fever) or perennial allergic rhinitis, other upper respiratory allergies, or the common cold.
Most effective in the treatment of chronic, nonproductive cough.
In pediatric patients <2 years of age, OTC cough and cold preparations (i.e., containing cough suppressants [including dextromethorphan], antihistamines, expectorants, and/or nasal decongestants) were not more effective than placebo in reducing acute cough and other symptoms of upper respiratory tract infection and reportedly are associated with adverse events and sometimes death (albeit rarely). (See Pediatric Use under Cautions.)
Abuse and recreational use reported. (See Abuse Potential under Cautions.)
Dextromethorphan Dosage and Administration
Administration
Oral Administration
Administer orally.
Dosage
Dosages of dextromethorphan hydrobromide and dextromethorphan polistirex are expressed in terms of dextromethorphan hydrobromide.
Because combinations and dosage strengths vary for fixed-combination preparations, consult manufacturer’s product labeling for appropriate dosage of the specific preparation.
Pediatric Patients
Cough
Immediate-release Preparations
OralChildren <2 years of age: Dosage must be individualized. Currently there are no FDA-approved dosage recommendations for cough and cold preparations for children <2 years of age. (See Pediatric Use under Cautions.)
Children 2 to <6 years of age: 2.5–5 mg every 4 hours or 7.5 mg every 6–8 hours, not to exceed 30 mg daily, or as directed by a clinician. (See Pediatric Use under Cautions.)
Children 6 to <12 years of age: 5–10 mg every 4 hours or 15 mg every 6–8 hours, not to exceed 60 mg daily, or as directed by a clinician.
Children ≥12 years of age: 10–20 mg every 4 hours or 30 mg every 6–8 hours, not to exceed 120 mg daily, or as directed by a clinician.
Extended-release Oral Suspension (containing polistirex)
OralChildren 2 to <6 years of age: 15 mg twice daily.
Children 6 to <12 years of age: 30 mg twice daily
Children ≥12 years of age: 60 mg twice daily.
Adults
Cough
Immediate-release Preparations
Oral10–20 mg every 4 hours or 30 mg every 6–8 hours, not to exceed 120 mg daily, or as directed by a clinician.
Extended-release Oral Suspension (containing polistirex)
Oral60 mg twice daily.
Prescribing Limits
Pediatric Patients
Cough
Oral
Children 2 to <6 years of age: Maximum 30 mg daily, or as directed by a clinician.
Children 6 to <12 years of age: Maximum 60 mg daily, or as directed by a clinician.
Children ≥12 years of age: Maximum 120 mg daily, or as directed by a clinician.
Adults
Cough
Oral
Maximum 120 mg daily, or as directed by a clinician.
Special Populations
Hepatic Impairment
No specific dosage recommendations for hepatic impairment.
Renal Impairment
No specific dosage recommendations for renal impairment.
Geriatric Patients
No specific geriatric dosage recommendations.
Cautions for Dextromethorphan
Contraindications
-
During or within 14 days of discontinuing MAO inhibitor therapy because of risk of serotonin syndrome. (See Interactions.)
-
Known hypersensitivity to the drug or any ingredient in the respective formulation.
Warnings/Precautions
Warnings
Persistent Cough
Do not take for persistent or chronic cough (e.g., with smoking, emphysema, asthma) or when coughing is accompanied by excessive secretions, unless directed by a clinician.
Consult a clinician for cough that persists for longer than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache.
Persistent cough may be a sign of a serious condition.
Sensitivity Reactions
May be associated with histamine release and should be used with caution in atopic children.
General Precautions
Sedated, Debilitated, and Supine Patients
Use with caution in sedated or debilitated patients and in patients confined to the supine position.
Phenylketonuria
Individuals with phenylketonuria and other individuals who must restrict their intake of phenylalanine should be warned that some commercially available preparations of dextromethorphan contain aspartame (NutraSweet), which is metabolized in the GI tract to phenylalanine.
Abuse Potential
Generally low, but recreational use reported with OTC dextromethorphan-containing preparations and with dextromethorphan powder sold illicitly.
Deaths possibly associated with ingestion of powdered dextromethorphan sold illicitly in capsules reported. Pure dextromethorphan in powder form reportedly is being encapsulated for illicit sale as a street drug.
Use of Fixed Combinations
When used in fixed combination with other agents (e.g., acetaminophen, brompheniramine, chlorpheniramine, doxylamine, guaifenesin, phenylephrine, pseudoephedrine), consider the cautions, precautions, and contraindications associated with the concomitant agent(s).
Specific Populations
Pregnancy
Category C.
Lactation
Unknown whether distributed into milk but likely based on low molecular weight. Preparations containing alcohol should be avoided in nursing women. Preparations that do not contain alcohol probably are safe.
Pediatric Use
Risk of overdosage and toxicity (including death) in children <2 years of age receiving OTC preparations containing antihistamines, cough suppressants, expectorants, and nasal decongestants alone or in combination for relief of symptoms of upper respiratory tract infection. Limited evidence of efficacy for these preparations in this age group; appropriate dosages not established. Therefore, FDA recommends not to use such preparations in children <2 years of age; safety and efficacy in older children under evaluation. Because children 2–3 years of age also are at increased risk of overdosage and toxicity, some manufacturers of oral nonprescription cough and cold preparations agreed to voluntarily revise the product labeling to state that such preparations should not be used in children <4 years of age. FDA recommends that parents and caregivers adhere to dosage instructions and warnings on the product labeling that accompanies the preparation and consult a clinician about any concerns. Clinicians should ask caregivers about use of OTC cough/cold preparations to avoid overdosage.
Efficacy of OTC cough and cold preparations in children <6 years of age also has been questioned. An FDA advisory panel recommended that these products not be used in these children; FDA has not yet announced its decision.
Do not use lozenges in children <6 years of age.
Do not use liquid-filled capsules in children <12 years of age, unless otherwise directed by a clinician.
Common Adverse Effects
Adverse effects with dextromethorphan are rare, but nausea and/or other GI disturbances, slight drowsiness, and dizziness sometimes occur.
Drug Interactions
Specific Drugs
Drug |
Interaction |
Comments |
---|---|---|
CNS depressants (e.g., alcohol, hypnotics, sedatives, tranquilizers, tricyclic antidepressants) |
Possible additive CNS depression |
|
MAO inhibitors |
Concomitant therapy may produce serotonin syndrome, which can manifest with serious complications (e.g., hypertensive crisis, hyperpyrexia, cardiac arrhythmias, myoclonus), including death |
Concomitant use with MAO inhibitors or within 2 weeks after discontinuance is contraindicated |
Dextromethorphan Pharmacokinetics
Absorption
Bioavailability
Rapidly and well absorbed from the GI tract.
Onset
Exerts antitussive effect in 15–30 minutes after oral administration.
Duration
Approximately 3–6 hours with conventional dosage forms.
Elimination
Metabolism
Undergoes hepatic metabolism.
Elimination Route
Excreted primarily in urine.
Stability
Storage
Oral
Tight, light-resistant containers.
Compatibility
Dextromethorphan is incompatible with penicillins, tetracyclines, salicylates, phenobarbital sodium, hydriodic acid, and high concentrations of sodium or potassium iodide.
Actions
-
Retains only the antitussive activity of other morphinan derivatives.
-
Acts centrally on the respiratory center in the medulla and nucleus tractus solaris to increase the cough threshold.
-
About equal to codeine in depressing the cough reflex and has no expectorant action.
Advice to Patients
-
Risk of drowsiness; avoid alcohol and use caution when driving, operating machinery, or engaging in other hazardous tasks.
-
Importance of warning individuals with phenylketonuria and other individuals who must restrict their intake of phenylalanine that some commercially available preparations of dextromethorphan contain aspartame (NutraSweet), which is metabolized in the GI tract to phenylalanine following oral administration.
-
Importance of contacting a clinician if cough persists for longer than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache.
-
Advise patient not to use for persistent or chronic cough (e.g., with smoking, emphysema, asthma) or when coughing is accompanied by excessive secretions, unless directed by a clinician.
-
Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs (e.g., other cough and cold preparations) as well as any concomitant illnesses.
Importance of not using during or within 14 days of discontinuing MAO inhibitor therapy because of the risk of serotonin syndrome, which is potentially fatal. Advise patients to consult their pharmacist or clinician if they do not know whether drugs they are taking contain an MAO inhibitor.
-
Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.
-
Importance of informing patients of other important precautionary information. (See Cautions.)
Preparations
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
Please refer to the ASHP Drug Shortages Resource Center for information on shortages of one or more of these preparations.
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes |
Dosage Forms |
Strengths |
Brand Names |
Manufacturer |
---|---|---|---|---|
Oral |
Capsules, liquid-filled |
15 mg |
Robitussin Long-Acting CoughGels |
Pfizer |
Lozenges |
5 mg |
Hold DM |
Ascher |
|
10 mg |
Sucrets DM Cough Formula |
Insight |
||
Solution |
7.5 mg/5 mL* |
Dextromethorphan Hydrobromide Solution |
||
10 mg/5 mL* |
Dextromethorphan Hydrobromide Solution |
|||
Vicks 44 Custom Care Dry Cough |
Procter & Gamble |
|||
15 mg/5 mL* |
Dextromethorphan Hydrobromide Solution |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes |
Dosage Forms |
Strengths |
Brand Names |
Manufacturer |
---|---|---|---|---|
Oral |
Capsules, liquid-filled |
10 mg with Acetaminophen 325 mg, Chlorpheniramine Maleate 2 mg, and Phenylephrine Hydrochloride 5 mg |
Alka-Seltzer Plus Cold & Cough Formula Liquid Gels |
Bayer |
Tylenol Cold Multi-Symptom Nighttime Rapid Release Gels |
McNeil |
|||
10 mg with Acetaminophen 325 mg, Doxylamine Succinate 6.25 mg, and Phenylephrine Hydrochloride 5 mg |
Alka-Seltzer Plus Night Cold Formula Liquid Gels |
Bayer |
||
10 mg with Acetaminophen 325 mg and Phenylephrine Hydrochloride 5 mg |
Alka-Seltzer Plus Day Cold Formula Liquid Gels |
Bayer |
||
Vicks DayQuil Cold & Flu Relief LiquiCaps |
Procter & Gamble |
|||
15 mg with Acetaminophen 325 mg and Doxylamine Succinate 6.25 mg |
Vicks NyQuil Cold & Flu Relief LiquiCaps |
Procter & Gamble |
||
For solution |
30 mg with Acetaminophen 1 g, Guaifenesin 400 mg, and Pseudoephedrine Hydrochloride 60 mg per packet |
TheraFlu Max-D Severe Cold & Flu |
Novartis |
|
Kit |
12 Tablets, film-coated, Acetaminophen 325 mg with Dextromethorphan Hydrobromide 10 mg and Phenylephrine Hydrochloride 5 mg (Comtrex Daytime Caplets) 12 Tablets, film-coated, Acetaminophen 325 mg with Chlorpheniramine Maleate 2 mg, Dextromethorphan Hydrobromide 10 mg, and Phenylephrine Hydrochloride 5 mg (Comtrex Nighttime Caplets) |
Comtrex Cold & Cough Day-Night Maximum Strength Caplets |
Novartis |
|
Solution |
3.3 mg/5 mL with Acetaminophen 108.3 mg/5 mL, Doxylamine Succinate 1.25 mg/5 mL, and Phenylephrine Hydrochloride 1.6 mg/5 mL |
Tylenol Cold Multi-Symptom Nighttime |
McNeil |
|
3.3 mg/5 mL with Acetaminophen 108.3 mg/5 mL, Guaifenesin 66.6 mg/5 mL, and Phenylephrine Hydrochloride 1.6 mg/5 mL |
Tylenol Cold Multi-Symptom Severe |
McNeil |
||
Tylenol Cold & Flu Severe |
McNeil |
|||
3.3 mg/5 mL with Acetaminophen 108.3 mg/5 mL and Phenylephrine Hydrochloride 1.6 mg/5 mL |
Tylenol Cold Multi-Symptom Daytime |
McNeil |
||
Vicks DayQuil Cold & Flu Relief |
Procter & Gamble |
|||
5 mg/5 mL with Acetaminophen 108.3 mg/5 mL and Doxylamine Succinate 2.08 mg/5 mL |
Vicks NyQuil Cold & Flu Relief |
Procter & Gamble |
||
5 mg/5 mL with Acetaminophen 160 mg/5 mL |
Children’s Tylenol Plus Cough & Sore Throat |
Prestige Brands |
||
TriaminicCough and Sore Throat |
Novartis |
|||
5 mg/5 mL with Acetaminophen 160 mg/5 mL and Chlorpheniramine Maleate 1 mg/5 mL |
Children’s Tylenol Plus Cough & Runny Nose |
McNeil |
||
5 mg/5 mL with Acetaminophen 160 mg/5 mL, Chlorpheniramine Maleate 1 mg/5 mL, and Phenylephrine Hydrochloride 2.5 mg/5 mL |
Children’s Dimetapp Multi-Symptom Cold & Flu |
Pfizer |
||
Children’s Tylenol Plus Flu |
McNeil |
|||
5 mg/5 mL with Acetaminophen 166.6 mg/5 mL |
Tylenol Cold & Cough Daytime |
McNeil |
||
5 mg/5 mL with Acetaminophen 166.6 mg/5 mL and Doxylamine Succinate 2.08 mg/5 mL |
Tylenol Cold & Cough Nighttime |
McNeil |
||
5 mg/5 mL with Brompheniramine Maleate 1 mg/5 mL and Phenylephrine Hydrochloride 2.5 mg/5 mL |
Children’s Dimetapp Cold & Cough |
Pfizer |
||
5 mg/5 mL with Chlorpheniramine Maleate 0.67 mg/5 mL |
Children’s Vicks NyQuil Cold/Cough |
Procter & Gamble |
||
5 mg/5 mL with Chlorpheniramine Maleate 1 mg/5 mL and Pseudoephedrine Hydrochloride 15 mg/5 mL |
Kidkare Cough & Cold Liquid |
Watson |
||
5 mg/5 mL with Doxylamine Succinate 2.08 mg/5 mL |
Vicks NyQuil Cough |
Procter & Gamble |
||
5 mg/5 mL with Guaifenesin 50 mg/5 mL and Phenylephrine Hydrochloride 2.5 mg/5 mL |
Robitussin Children’s Cough & Cold CF |
Pfizer |
||
5 mg/5 mL with Guaifenesin 100 mg/5 mL |
Pediacare Cough & Congestion |
Prestige Brands |
||
5 mg/5 mL with Phenylephrine Hydrochloride 2.5 mg/5 mL |
Children’s Sudafed PE Cold & Cough |
McNeil |
||
Pediacare Multi-Symptom Cold |
Prestige Brands |
|||
Triaminic Daytime Cold & Cough |
Novartis |
|||
6.7 mg/5 mL with Guaifenesin 66.7 mg/5 mL |
Vicks Formula 44 Custom Care Chesty Cough |
Procter & Gamble |
||
7.5 mg/5 mL with Acetaminophen 160 mg/5 mL and Chlorpheniramine Maleate 1 mg/5 mL |
Triaminic Multi-Symptom Fever |
Novartis |
||
10 mg/5 mL with Acetaminophen 216.7 mg/5 mL and Chlorpheniramine Maleate 1.3 mg/5 mL |
Vicks Formula 44 Custom Care Cough & Cold PM |
Procter & Gamble |
||
10 mg/5 mL with Guaifenesin 100 mg/5 mL* |
Cheracol D Cough Formula |
Lee |
||
Dextromethorphan Hydrobromide with Guaifenesin Syrup |
||||
Diabetic Tussin DM |
Health Care Products |
|||
Guiatuss DM |
Goldline |
|||
Robitussin Peak Cold Cough + Chest Congestion DM |
Pfizer |
|||
Robitussin Sugar-Free Cough + Chest Congestion DM |
Pfizer |
|||
10 mg/5 mL with Guaifenesin 100 mg/5 mL and Phenylephrine Hydrochloride 5 mg/5 mL* |
Robitussin Peak Cold Multi-Symptom Cold |
Pfizer |
||
10 mg/5 mL with Guaifenesin 200 mg/5 mL |
Diabetic Tussin DM Maximum Strength |
Health Care Products |
||
Robitussin Maximum Strength Cough + Chest Congestion |
Pfizer |
|||
Robitussin Peak Cold Maximum Strength Cough + Chest Congestion |
Pfizer |
|||
15 mg/5 mL with Guaifenesin 100 mg/5 mL* |
Safe Tussin |
Kramer |
||
15 mg/5 mL with Promethazine Hydrochloride 6.25 mg/5 mL* |
Promethazine Hydrochloride with Dextromethorphan Hydrobromide Cough Syrup |
|||
5 mg/mL with Guaifenesin 50 mg/mL and Phenylephrine Hydrochloride 2.5 mg/mL |
Suppress DX Pediatric Drops |
Kramer Novis |
||
Suspension |
5 mg/5 mL with Acetaminophen 160 mg/5 mL |
Pediacare Fever Reducer Plus Cough & Sore Throat |
Prestige Brands |
|
5 mg/5 mL with Acetaminophen 160 mg/5 mL and Chlorpheniramine Maleate 1 mg/5 mL |
Pediacare Fever Reducer Plus Cough & Runny Nose |
Prestige Brands |
||
5 mg/5 mL with Acetaminophen 160 mg/5 mL, Chlorpheniramine Maleate 1 mg/5 mL, and Phenylephrine Hydrochloride 2.5 mg/5 mL |
Children’s Tylenol Plus Multi-Symptom Cold |
McNeil |
||
Pediacare Fever Reducer Plus Multi-Symptom Cold |
Prestige Brands |
|||
Pediacare Fever Reducer Plus Flu |
Prestige Brands |
|||
5 mg/5 mL with Acetaminophen 160 mg/5 mL and Phenylephrine Hydrochloride 2.5 mg/5 mL |
Pediacare Fever Reducer Plus Cold & Cough |
Prestige Brands |
||
Tablets |
10 mg with Acetaminophen 325 mg, Guaifenesin 200 mg, and Phenylephrine Hydrochloride 5 mg |
Tylenol Cold & Flu Severe |
McNeil |
|
Tylenol Cold Head Congestion Severe |
McNeil |
|||
10 mg with Acetaminophen 325 mg and Phenylephrine Hydrochloride 5 mg |
Tylenol Cold Multi-Symptom Daytime |
McNeil |
||
10 mg with Acetaminophen 325 mg and Phenylephrine Hydrochloride 15 mg |
Comtrex Cold & Cough Multi-Symptom Relief Maximum Strength Tablets |
Novartis |
||
30 mg with Chlorpheniramine Maleate 4 mg |
Coricidin HBP Cough & Cold |
Schering-Plough |
||
Tablets, chewable |
10 mg with Chlorpheniramine Maleate 2 mg and Pseudoephedrine Hydrochloride 30 mg |
Dicel DM |
Centrix |
|
Tablets, extended-release |
15 mg with Acetaminophen 500 mg and Chlorpheniramine Maleate 2 mg |
Coricidin HBP Flu Maximum Strength |
Schering-Plough |
|
30 mg with Guaifenesin 600 mg |
Mucinex DM |
Reckitt Benckiser |
||
60 mg with Guaifenesin 1200 mg |
Maximum Strength Mucinex DM |
Reckitt Benckiser |
||
Tablets, film-coated |
10 mg with Acetaminophen 325 mg, Chlorpheniramine Maleate 2 mg, and Phenylephrine Hydrochloride 5 mg |
TheraFlu Warming Relief Caplets Nighttime Multi-Symptom Cold |
Novartis |
|
10 mg with Acetaminophen 325 mg and Phenylephrine Hydrochloride 5 mg |
Comtrex Non-Drowsy Maximum Strength Caplets |
Novartis |
||
TheraFlu Warming Relief Caplets Daytime Multi-Symptom Cold |
Novartis |
|||
Tylenol Cold Multi-Symptom Daytime |
McNeil |
|||
15 mg with Acetaminophen 325 mg, Guaifenesin 200 mg, and Phenylephrine Hydrochloride 5 mg |
Tylenol Cold Head Congestion Severe |
McNeil |
Routes |
Dosage Forms |
Strengths |
Brand Names |
Manufacturer |
---|---|---|---|---|
Oral |
Suspension, extended-release |
equivalent to Dextromethorphan Hydrobromide 30 mg/5 mL |
Delsym |
Reckitt Benckiser |
AHFS DI Essentials™. © Copyright 2024, Selected Revisions February 1, 2016. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.
Reload page with references included
Frequently asked questions
- Does Mucinex help with Covid?
- Dextromethorphan - can you give TusQ Dx to a child and what is the dose?
More about dextromethorphan
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (385)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: antitussives
- Breastfeeding